Treatments for Neuromyelitis Optica
FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.
ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing dataFDA-approved treatments (0)
No FDA-approved treatments for Neuromyelitis Optica are tracked on UniteRare yet. Clinical trials may be available — see the trials page.
Patient support programs (2)
Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.
UPLIZNA
Amgen
Neuromyelitis Optica
Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications
Enspryng
Genentech
Neuromyelitis Optica
Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications
Travel grants (15)
- PAN Foundation Neuromyelitis Optica Spectrum Disorder Patient Assistance GrantPAN FoundationUp to $8,000Apply →
- Amgen SupportPlus Patient Support ProgramAmgenApply →
- Amgen Patient Assistance ProgramAmgenApply →
- PAN Foundation Neuromyelitis Optica Spectrum Disorder FundPAN FoundationUp to $8,000Apply →
- Genentech Access to CareGenentechApply →
- Genentech Patient AssistanceGenentechApply →
- Amgen Assist 360AmgenApply →
- NORD RareCare Patient Assistance ProgramNational Organization for Rare Disorders, Inc. (NORD)Apply →
- Enspryng Co-Pay ProgramThe Assistance FundApply →
- AMGEN AssistAmgenApply →
- Amgen By Your Side Patient Assistance Program: UpliznaAmgenApply →
- Genentech Transplant Access Services (GTAS)GenentechApply →
- Amgen Support PlusAmgenApply →
- Amgen Support PlusAmgenApply →
- Amgen Assist 360AmgenApply →